Canada Aesthetic Injectable Market, 2026-2033
Global Market
Related Markets
Canada aesthetic injectable market highlights
- The Canada aesthetic injectable market generated a revenue of USD 337.4 million in 2025 and is expected to reach USD 604.0 million by 2033.
- The Canada market is expected to grow at a CAGR of 7.4% from 2026 to 2033.
- In terms of segment, hyaluronic acid was the largest revenue generating product in 2025.
- Hyaluronic Acid is the most lucrative product segment registering the fastest growth during the forecast period.
Aesthetic injectable market data book summary
| Market revenue in 2025 | USD 337.4 million |
| Market revenue in 2033 | USD 604.0 million |
| Growth rate | 7.4% (CAGR from 2026 to 2033) |
| Largest segment | Hyaluronic acid |
| Fastest growing segment | Hyaluronic Acid |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, Botulinum Toxin (Botox) |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.0% of the global aesthetic injectable market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,074.5 million by 2033.
Canada’s aesthetic injectable market is expected to be driven by the growing number of players entering into strategic partnerships and undertaking novel product launches. For instance, in June 2023, Galderma launched Restylane Eyelight in Canada.
The product aims to correct infraorbital hollowing. Moreover, clinical evidence of the product’s efficacy is expected to propel its adoption across regions. According to the same source, 84% of the patients who received the product made positive statements about it. Nearly 94% of patients said they would recommend the product to acquaintances.
Furthermore, in January 2021, Crescita Therapeutics, Inc. submitted an application to Health Canada for its ART-FILLER injectables product range, which includes five HA-based dermal fillers. The Canadian Association of Medical Spas and Aesthetic Surgeons (CAMACS) recognizes the need for proper guidelines due to the increasing number of cosmetic procedures in nonclinical settings.
No credit card required*
Publish Date: Apr 28, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Aesthetic Injectable Market
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Galderma Group AG Registered Shares | View profile | - | Zählerweg 10, Zug, Switzerland, 6300 | www.galderma.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | www.revance.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Suneva Medical | View profile | 101-250 | San Diego, California, United States, North America | sunevamedical.com |
| Prollenium Medical Technologies | View profile | 101-250 | Richmond Hill, Ontario, Canada, North America | prollenium.com |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | www.sinclairpharma.com/ |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.medytox.com/page/company_en?site_id=en |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
Canada Aesthetic Injectable Market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Hyaluronic Acid was the largest segment with a revenue share of 57.77% in 2025.
Horizon Databook has segmented the Canada aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
Canada’s aesthetic injectable market is expected to be driven by the growing number of players entering into strategic partnerships and undertaking novel product launches. For instance, in June 2023, Galderma launched Restylane Eyelight in Canada.
The product aims to correct infraorbital hollowing. Moreover, clinical evidence of the product’s efficacy is expected to propel its adoption across regions. According to the same source, 84% of the patients who received the product made positive statements about it. Nearly 94% of patients said they would recommend the product to acquaintances.
Furthermore, in January 2021, Crescita Therapeutics, Inc. submitted an application to Health Canada for its ART-FILLER injectables product range, which includes five HA-based dermal fillers. The Canadian Association of Medical Spas and Aesthetic Surgeons (CAMACS) recognizes the need for proper guidelines due to the increasing number of cosmetic procedures in nonclinical settings.
- Canada Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
- Canada Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
- Canada Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others
Reasons to subscribe to Aesthetic Injectable Market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
- Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into Canada Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Canada Aesthetic Injectable Market, 2021-2033 (US$M)
Canada Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)
